321 related articles for article (PubMed ID: 33445036)
21. The role of self-reported smell and taste disorders in suspected COVID‑19.
Printza A; Constantinidis J
Eur Arch Otorhinolaryngol; 2020 Sep; 277(9):2625-2630. PubMed ID: 32447496
[TBL] [Abstract][Full Text] [Related]
22. Prevalence of anosmia among COVID-19 patients in Taif City, Kingdom of Saudi Arabia.
Mubaraki AA; Alrbaiai GT; Sibyani AK; Alhulayfi RM; Alzaidi RS; Almalki HS
Saudi Med J; 2021 Jan; 42(1):38-43. PubMed ID: 33399169
[TBL] [Abstract][Full Text] [Related]
23. COVID-19, anosmia, and ageusia in atopic children.
Parisi GF; Brindisi G; Indolfi C; Diaferio L; Marchese G; Ghiglioni DG; Zicari AM; Miraglia Del Giudice M
Pediatr Allergy Immunol; 2022 Jan; 33 Suppl 27(Suppl 27):99-101. PubMed ID: 35080301
[TBL] [Abstract][Full Text] [Related]
24. Potential pharmacologic treatments for COVID-19 smell and taste loss: A comprehensive review.
Khani E; Khiali S; Beheshtirouy S; Entezari-Maleki T
Eur J Pharmacol; 2021 Dec; 912():174582. PubMed ID: 34678243
[TBL] [Abstract][Full Text] [Related]
25. Loss of Taste and Smell are Common Clinical Characteristics of Patients with COVID-19 in Somalia: A Retrospective Double Centre Study.
Farah Yusuf Mohamud M; Garad Mohamed Y; Mohamed Ali A; Ali Adam B
Infect Drug Resist; 2020; 13():2631-2635. PubMed ID: 32801800
[TBL] [Abstract][Full Text] [Related]
26. Negative correlation between ACE2 gene expression levels and loss of taste in a cohort of COVID-19 hospitalized patients: New clues to long-term cognitive disorders.
Braga-Paz I; Ferreira de Araújo JL; Alves HJ; de Ávila RE; Resende GG; Teixeira MM; de Aguiar RS; de Souza RP; Bahia D
Front Cell Infect Microbiol; 2022; 12():905757. PubMed ID: 36250059
[TBL] [Abstract][Full Text] [Related]
27. [Anosmia and ageusia as primary symptoms of COVID-19].
Haldrup M; Johansen MI; Fjaeldstad AW
Ugeskr Laeger; 2020 Apr; 182(18):. PubMed ID: 32400371
[TBL] [Abstract][Full Text] [Related]
28. Prevalence of Self-Reported Anosmia and Ageusia in Elderly Patients Who Had Been Previously Hospitalized by SARS-CoV-2: The LONG-COVID-EXP Multicenter Study.
Fernández-de-Las-Peñas C; Ortega-Santiago R; Cancela-Cilleruelo I; Rodríguez-Jiménez J; Fuensalida-Novo S; Martín-Guerrero JD; Pellicer-Valero ÓJ; Cigarán-Méndez M
J Clin Med; 2023 Jun; 12(13):. PubMed ID: 37445426
[TBL] [Abstract][Full Text] [Related]
29. Distorted chemosensory perception and female sex associate with persistent smell and/or taste loss in people with SARS-CoV-2 antibodies: a community based cohort study investigating clinical course and resolution of acute smell and/or taste loss in people with and without SARS-CoV-2 antibodies in London, UK.
Makaronidis J; Firman C; Magee CG; Mok J; Balogun N; Lechner M; Carnemolla A; Batterham RL
BMC Infect Dis; 2021 Feb; 21(1):221. PubMed ID: 33632171
[TBL] [Abstract][Full Text] [Related]
30. Prevalence of Anosmia and Ageusia in Patients with COVID-19 at a Primary Health Center, Doha, Qatar.
Al-Ani RM; Acharya D
Indian J Otolaryngol Head Neck Surg; 2022 Oct; 74(Suppl 2):2703-2709. PubMed ID: 32837952
[TBL] [Abstract][Full Text] [Related]
31. Subjective evaluation of smell and taste dysfunction in patients with mild COVID-19 in Spain.
Ninchritz-Becerra E; Soriano-Reixach MM; Mayo-Yánez M; Calvo-Henríquez C; Martínez-Ruiz de Apodaca P; Saga-Gutiérrez C; Parente-Arias P; Villareal IM; Viera-Artiles J; Poletti-Serafini D; Alobid I; Ayad T; Saussez S; Lechien JR; Chiesa-Estomba CM
Med Clin (Barc); 2021 Jan; 156(2):61-64. PubMed ID: 33168151
[TBL] [Abstract][Full Text] [Related]
32. Prevalence of Anosmia or Ageusia in Patients With COVID-19 Among United Arab Emirates Population.
Al-Rawi NH; Sammouda AR; AlRahin EA; Ali FAA; Arayedh GSA; Daryanavard HA; Saeed MH; Nuaimi ASA
Int Dent J; 2022 Apr; 72(2):249-256. PubMed ID: 34226066
[TBL] [Abstract][Full Text] [Related]
33. Reversible Taste Loss in a COVID-19 Patient With Preexisting Chronic Smell Impairment.
Klein H; Karni N; Israel S; Gross M; Muszkat M; Niv MY
J Investig Med High Impact Case Rep; 2021; 9():2324709621990765. PubMed ID: 33535814
[TBL] [Abstract][Full Text] [Related]
34. Photobiomodulation therapy for treatment olfactory and taste dysfunction COVID-19-related: A case report.
de Souza VB; Ferreira LT; Sene-Fiorese M; Garcia V; Rodrigues TZ; de Aquino Junior AE; Bagnato VS; Panhoca VH
J Biophotonics; 2022 Aug; 15(8):e202200058. PubMed ID: 35445797
[TBL] [Abstract][Full Text] [Related]
35. Evolution of olfactory and gustatory dysfunctions in COVID-19 patients in India.
Sahoo PR; Sahu M; Surapaneni PS; Maiti A; Vankamamidi R; Panda N; Biswal RN
Eur Arch Otorhinolaryngol; 2021 Aug; 278(8):2875-2881. PubMed ID: 33392762
[TBL] [Abstract][Full Text] [Related]
36. Prevalence of Loss of Smell and/or Taste and other Otorhinolaryngology Symptoms in COVID-19 Patients.
Shrestha I; Mishra A; Mishra A; Bista M; Acharya J
Kathmandu Univ Med J (KUMJ); 2021; 19(74):173-179. PubMed ID: 34819431
[TBL] [Abstract][Full Text] [Related]
37. Taste and Smell Impairment in Critically Ill Patients With COVID-19: An Intensive Care Unit Study.
Sayın P; Altınay M; Cınar AS; Ozdemir HM
Ear Nose Throat J; 2021 Apr; 100(2_suppl):174S-179S. PubMed ID: 33258690
[TBL] [Abstract][Full Text] [Related]
38. Implementing a COVID-19 specialist smell clinic: experience at the Wrightington, Wigan and Leigh Teaching Hospitals (WWL), NHS Foundation Trust, United Kingdom.
Chu M; Gopikrishna D; Rocke J; Kumar BN
Med J Malaysia; 2021 Aug; 76(Suppl 4):9-13. PubMed ID: 34558550
[TBL] [Abstract][Full Text] [Related]
39. Tracking COVID-19 using taste and smell loss Google searches is not a reliable strategy.
Asseo K; Fierro F; Slavutsky Y; Frasnelli J; Niv MY
Sci Rep; 2020 Nov; 10(1):20527. PubMed ID: 33239650
[TBL] [Abstract][Full Text] [Related]
40. Eating Habits and Body Weight Changes Induced by Variation in Smell and Taste in Patients with Previous SARS-CoV-2 Infection.
Ferrulli A; Senesi P; Terruzzi I; Luzi L
Nutrients; 2022 Nov; 14(23):. PubMed ID: 36501098
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
